ANAB

ANAB R&D Expenses

$93.53MTTM · USD

Period ending:

ANAB FY R&D ExpensesUSD
ANAB FY R&D Expenses2013-12-31: $8.82M2014-12-31: $8.61M2015-12-31: $17.30M2016-12-31: $22.62M2017-12-31: $30.94M2018-12-31: $56.30M2019-12-31: $99.34M2020-12-31: $80.03M2021-12-31: $98.50M2022-12-31: $88.80M2023-12-31: $139.62M2024-12-31: $163.84M2025-12-31: $135.97M$163.84M$0.00
2013-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ANAB r&d expenses history

Research and development spending. The available annual fiscal periods series contains 13 observations from Dec 31, 2013 to Dec 31, 2025.

Anaptysbio Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
135,970,000
163,840,000
139,622,000
88,798,000
98,496,000
80,025,000
99,338,000
56,296,000
30,943,000
22,619,000
17,304,000
8,614,000
8,820,000

Compare r&d expenses

All ANAB financial metrics · ANAB stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.